Pierre P, Mellman I
Department of Cell Biology, Yale University School of Medicine, New Haven, Connecticut 06520-8002, USA.
Cell. 1998 Jun 26;93(7):1135-45. doi: 10.1016/s0092-8674(00)81458-0.
Dendritic cells (DCs) developmentally regulate their capacity for antigen presentation by controlling the transport and surface expression of MHC class II molecules. These events reflect a developmental regulation of invariant (Ii) chain cleavage, most likely by the cysteine protease cathepsin S. In immature DCs, inefficient Ii chain cleavage due to low cathepsin S activity leads to the transport of class II-Ii chain complexes to lysosomes, while in mature DCs, elevated cathepsin S activity results in efficient delivery of class II alphabeta dimers to the plasma membrane. Cathepsin S is not controlled transcriptionally but by a novel mechanism involving alterations in the expression and localization of an endogenous cathepsin S inhibitor cystatin C. Thus, the ratio of cystatin C to cathepsin S in developing DCs helps to determine the fate of newly synthesized MHC class II molecules.
树突状细胞(DCs)通过控制MHC II类分子的转运和表面表达,在发育过程中调节其抗原呈递能力。这些事件反映了恒定链(Ii)裂解的发育调控,最有可能是由半胱氨酸蛋白酶组织蛋白酶S介导的。在未成熟的DCs中,由于组织蛋白酶S活性低,Ii链裂解效率低下,导致II类-Ii链复合物转运至溶酶体,而在成熟的DCs中,组织蛋白酶S活性升高导致II类αβ二聚体有效递送至质膜。组织蛋白酶S不是通过转录调控,而是通过一种涉及内源性组织蛋白酶S抑制剂胱抑素C表达和定位改变的新机制进行调控。因此,发育中的DCs中胱抑素C与组织蛋白酶S的比例有助于确定新合成的MHC II类分子的命运。